Cardiff Park Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$327K Hold
1,118
0.03% 221
2025
Q4
$392K Hold
1,118
0.03% 193
2025
Q3
$361K Hold
1,118
0.03% 217
2025
Q2
$435K Hold
1,118
0.04% 186
2025
Q1
$486K Hold
1,118
0.05% 164
2024
Q4
$412K Hold
1,118
0.04% 177
2024
Q3
$581K Sell
1,118
-10
-0.9% -$5.34K 0.05% 146
2024
Q2
$611K Hold
1,128
0.06% 136
2024
Q1
$585K Hold
1,128
0.06% 150
2023
Q4
$532K Hold
1,128
0.06% 148
2023
Q3
$491K Hold
1,128
0.06% 145
2023
Q2
$501K Hold
1,128
0.06% 144
2023
Q1
$519K Hold
1,128
0.07% 135
2022
Q4
$579K Hold
1,128
0.08% 129
2022
Q3
$512K Sell
1,128
-32
-3% -$15.3K 0.08% 139
2022
Q2
$560K Sell
1,160
-8
-0.7% -$3.96K 0.08% 130
2022
Q1
$574K Buy
1,168
+40
+4% +$18.3K 0.08% 128
2021
Q4
$523K Buy
+1,128
New +$475K 0.07% 134

Other funds holding ELV

Cardiff Park Advisors's ELV Position: Q1 2026 in Review

Cardiff Park Advisors held its Elevance Health (ELV) position steady in Q1 2026 at 1,118 shares worth $327K. The position accounts for 0.03% of the portfolio, ranked #221.

Cardiff Park Advisors first reported a position in ELV in Q4 2021 and has held it in 18 quarters since. The position peaked at $611K in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Cardiff Park Advisors held 1,118 shares of Elevance Health worth $327K as of Q1 2026.
  • Cardiff Park Advisors left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.03% of Cardiff Park Advisors's portfolio in Q1 2026, its #221 holding.
  • Cardiff Park Advisors first reported a position in Elevance Health in Q4 2021 and has held it in 18 quarters since.
  • Cardiff Park Advisors's Elevance Health position peaked at $611K in Q2 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Cardiff Park Advisors's 13F filing for Q1 2026, filed 15 May 2026.